In this study, we use magnetic resonance spectroscopy (MRS) at 3 Tesla to measure N-acetyl aspartate (NAA), myo-inositol (mI) and choline (Cho) to creatine (Cr) ratios in R (right) and L (left) hippocampi (H) in 8 mildly memory impaired (MMI), 6 probable Alzheimer's Disease (PRAD), and 17 control subjects. NAA/Cr was significantly reduced in the RH in the MMI group and bilaterally in the PRAD group vs. controls. No other metabolite differences were noted between the three groups. Five MMI subjects have converted to PRAD in follow-up. These findings suggest that RH NAA/Cr ratios measured at 3 Tesla may be a sensitive marker of future progression to dementia in a clinically defined population with isolated memory complaints.
Introduction
Individuals with mild cognitive impairment (MCI) include a heterogeneous group of subjects, many of whom are at significantly increased risk for Alzheimer 's Disease (AD). The clinical definition of MCI remains somewhat broad, although amnestic MCI presents with prominent memory impairment and is a significant risk factor for progression to AD (Petersen et al., 2001; Modrego et al., 2005) . Patients often present to memory disorder clinics with memory complaints but may not yet meet specific neuropsychological criteria for amnestic MCI. The risk for progression to further cognitive impairment for this mild memory impaired group is unknown. Markers such as APOE 4 have been used to assess increased risk for conversion to AD but are not in general clinical practice at present. Volumetric magnetic resonance imaging (MRI) measures of medial temporal lobe structures have been studied and found to be very useful in predicting conversion from MCI to AD. Volumetric MRI studies have found more pronounced atrophy in the right vs. the left hippocampus among subjects at genetic risk for AD (Soininen et al., 1995; Lehtovirta et al., 2000; Tapiola et al., 2008) and in age-associated memory impairment, a possible precursor to MCI (Soininen et al., 1994; Mega et al., 2002) . These methods are labor intensive, however, and not suitable as a screening measure in the clinic. 
